
Washington D.C. Cardiology Conference
The prestigious Division of Cardiology at Rabin Medical Center, headed by Prof. Alexander Battler, is the leading facility for heart patients in Israel. Its Institute of Interventional Cardiology, directed by the renowned Prof. Ran Kornowski, together with the Catheterization Unit at Schneider Children's Medical Center of Israel, presented three catheterization procedures by live broadcast to participants at the world's largest and most prestigious interventional cardiology conference in Washington D.C. The conference was attended by more than 10,000 cardiologists. The three procedures involved both adult and pediatric cardiology, and Prof. Ran Kornowski said that the Israeli team complex catheterization procedures that are among the most advanced in the world, including a new generation modular coated stent and a virtual imaging technique utilized in Rabin Medical Center's Catheterization Laboratory. One procedure performed was a catheterization to open a blocked artery, utilizing new virtual catheterization technology (Angio CT) and a novel drug-eluting stent, "Endeavour Resolute", developed in Israel.
Rabin Medical Center and Schneider Children's Medical Center are both part of Clalit Health Services, share the same campus and cooperate closely. Together they perform over 5,000 catheterization procedures annually, which is the largest number in any medical center in Israel today.
Kfar Kassem is a hilltop Arab-Israeli city located about twenty kilometers east of Tel Aviv, near the Green Line separating Israel and the West Bank.
As one of the leading departments of orthopedic surgery in Israel, the Orthopedic Department at Rabin Medical Center treats patients of all ages including many young soldiers of the Israel Defense Forces. They use the most advanced medical techniques for the benefit of all their patients.
A researcher at Zebra Medical Vision has created a new mammography algorithm that uses machine and deep learning to diagnose breast cancer (BC), with results that the company claims are superior to those achieved using current methods.